Purchases and Sales Made in Q3 2023 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q3 2023. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-253K- 45.65% |
$4.97M - $7.17M
|
302K
$905K
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-387K- 92.35% |
$7.6M - $11M
|
32.1K
$96.2K
|
|
|
Nov 14, 2023
Q3 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-395K- 36.07% |
$7.75M - $11.2M
|
700K
$2.1M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-450K- 14.26% |
$8.82M - $12.7M
|
2.7M
$8.11M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-510K- 69.57% |
$10M - $14.4M
|
223K
$670K
|
|
|
Nov 14, 2023
Q3 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-1.26M- 95.63% |
$24.8M - $35.8M
|
57.7K
$173K
|